Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pituitary tumours.

J R Davis1, W E Farrell, R N Clayton

  • 1Endocrine Sciences Research Group, Faculty of Medicine, University of Manchester, Manchester M13 9PT, UK. julian.davis@man.ac.uk

Reproduction (Cambridge, England)
|February 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Necrosis drives susceptibility to <i>Mycobacterium tuberculosis</i> in Polg<sup>D257A</sup> mutator mice.

Infection and immunity·2025
Same author

The acute management of Pilon fractures (ENFORCE) study: a national evaluation of practice.

Annals of the Royal College of Surgeons of England·2024
Same author

Necrosis drives susceptibility to <i>Mycobacterium tuberculosis</i> in Polg<sup>D257A</sup> mutator mice.

bioRxiv : the preprint server for biology·2024
Same author

What is a tibial pilon fracture and how should they be acutely managed? A survey of consultant British Orthopaedic Foot and Ankle Society members and non-members.

Annals of the Royal College of Surgeons of England·2023
Same author

Reliable Initial Trauma CT Findings of Supraclavicular Brachial Plexus Injury in Patients Sustaining Blunt Injuries.

AJNR. American journal of neuroradiology·2023
Same author

Comments on the Feature "Potato Early Dying: Management Challenges in a Changing Production Environment".

Plant disease·2019
Same journal

Single-cell Transcriptomic Atlas of Ovarian Endometriosis Patient's Follicular Fluid: Unraveling Novel Insights into Abnormal Follicular Development.

Reproduction (Cambridge, England)·2026
Same journal

PGRMC1 suppression enhances progesterone responsiveness in stromal cells of ovarian endometrioma.

Reproduction (Cambridge, England)·2026
Same journal

Mitochondrial-derived peptide Humanin protects granulosa cells under oxidative conditions.

Reproduction (Cambridge, England)·2026
Same journal

Spatial Transcriptomics in Ovarian Biology Technologies, Computational Challenges, and Biological Insights.

Reproduction (Cambridge, England)·2026
Same journal

Toll-like Receptor 4 Knockout Mice are Protected Against PMOS-like Pathogenesis.

Reproduction (Cambridge, England)·2026
Same journal

Evidence That Heat Shock Protein A5 (HSPA5) Plays a Role During Bovine In Vitro Embryo Production.

Reproduction (Cambridge, England)·2026
See all related articles

Pituitary tumors, common brain neoplasms, arise from genetic mutations and cause endocrine issues. Gene therapy offers new hope for aggressive pituitary tumors resistant to current treatments.

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Pituitary tumors are common intracranial neoplasms with varied endocrine and reproductive effects.
  • Their development involves transcription factor cascades; mutations cause hypopituitarism.
  • Tumorigenesis involves oncogene activation (e.g., gsp) or tumor suppressor gene inactivation (e.g., MEN1).

Purpose of the Study:

  • To review the developmental biology and genetic basis of pituitary tumors.
  • To discuss current treatment modalities and their limitations.
  • To explore the potential of gene therapy for aggressive pituitary tumors.

Main Methods:

  • Literature review of pituitary tumor development, genetics, and treatment.
  • Analysis of oncogenes, tumor suppressor genes, and DNA methylation in tumorigenesis.

Related Experiment Videos

  • Evaluation of current therapies including medical, surgical, and radiotherapeutic approaches.

    • Main Results:

    • Pituitary tumor development is linked to specific transcription factor mutations and oncogene/tumor suppressor gene alterations.
    • Abnormal DNA methylation may contribute to tumor suppressor gene silencing.
    • Current treatments (medical, surgical, radiotherapy) have limitations for aggressive cases.

    Conclusions:

    • Understanding pituitary tumor genetics is crucial for targeted therapies.
    • Gene therapy presents a promising avenue for managing refractory pituitary tumors.
    • Further research into novel therapeutic strategies is warranted.